Deargen

Deargen, Inc. was founded in December 2016 as a biotech startup developing a drug discovery platform using artificial intelligence technology. By integrating AI and collective intelligence, the company advances treatments for rare and challenging diseases. Its team consists of diverse experts from deep learning, software, biology, and bioinformatics backgrounds, all committed to drug discovery. This exceptional team acts faster than anyone else, continuously tackling new challenges. UG Doctor is an AI-powered drug discovery platform based on Deargen’s deep learning technology. It focuses on the early stages of drug discovery research, from target identification to lead optimization. Compared to traditional methods, UG Doctor saves time and cost. Today, Deargen is collaborating with pharmaceutical companies and research institutions to apply its computational platform to the development pipeline of drug discovery projects.